Sanofi-Aventis Deutschland GmbH

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2021🗂️ Report periods on file: 2021

In its 2021 reporting, Sanofi-Aventis Deutschland GmbH disclosed greenhouse gas emissions of 11.4K tCO2e (2020). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
11.4K tCO2e (2020)
2021
⚡
Renewable Energy
100% (Berlin and Frankfurt, 2021)
of total energy
💧
Water Usage
4.9M m3 (2021)
2021
♻️
Waste
15.6K tons (2021)
2021
⚙️
Energy Use
4.9M MWh (2020)
2021

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce water consumption by 10% by 2025 (global target, progress in Germany reported)
  • 100% blister-free vaccines by 2027 (global target, progress in Germany reported)
  • 100% eco-design for all new products by 2025 (global target, progress in Germany reported)

📅 Medium-term

  • Climate neutrality for all emissions by 2030 (global target, progress in Germany reported)
  • 100% renewable energy for all sites by 2030 (global target, progress in Germany reported)
  • 50:50 gender balance in top 2000 leadership positions by 2025 (global target, progress in Germany reported)

🔭 Long-term

  • Net-zero emissions by 2050 (global target)

🌱 ESG Focus Areas

Health Care AccessResearch and Development for unmet needsPlanet Care (Resource Management)Beyond the Workplace (Social Responsibility)

⚠️ Challenges & Risks +

  • Supply chain disruptions (not explicitly stated, but implied by discussion of supplier management)
  • Climate change impacts (implied by discussion of climate mitigation strategies)
  • Competition in the pharmaceutical industry (mentioned in risks section)
  • Patent expiration for some products (mentioned in risks section)

📋 Report Information

Reporting Period: 2021
Frameworks: GRI